I think the stock should be trading up slightly. I guess the down market day is pulling them down too. Also, I can't help but think that some investors are losing patience with AVAV. Afterall, they really have gone nowhere in the last few years. But, my what I really want to know is, "Why is this message board so dead?"
This has to be one of the most undervalued big cap biotechs on the market. They are projected to have nearly $10 in earnings this year and they are trading at just a little over 10 times earnings. With current biotech valuations, I can't see why this stock isn't trading at $150/ per share.